Structure de mise en forme 2 colonnes

Institut Curie (CURIE)

The Curie Institute is a non-profit foundation dedicated to cancer research and treatment. It was founded by Marie Curie, her family, and strong financial support by Rothschild group, with the aim of applying the progress of science to human health.

This interdisciplinary spirit is still at the heart of the Institute’s strategy, and Curie is recognized as one of Europe’s best places for interdisciplinary research and translational medicine. It is partner of the major National and Regional research and higher education establishments, such as CNRS, INSERM, and University Pierre et Marie Curie. It is at the heart of the Montagne Ste Geneviève Campus, comprising the highest density of high excellence interdisciplinary research and education in France, and a cofounder and partner, the Pierre Gilles de Gennes Foundation. The Institute as a whole is also strongly involved in the development of innovative technologies and drugs for medicine, and has an active IP protection and exploitation policy. It is has been the origin of several start-ups in the last years.


Department(s) involved:

  • Macromolecules and Microsystems in Biology and Medicine group (MMBM)
    Group MMBM is part of the Curie Institute/CNRS Department UMR168, ~140 persons, the largest laboratory in France entirely dedicated to research at the interface between Physics, Chemistry, Biology and Medicine. MMBM is a multidisciplinary team of about 25 persons, dedicated to the development of innovative tools for biology and medicine using research in physics and chemistry. Thus, the project is right in line of the group’s main interest. Important internal resources of the group will be applied to the project, offering a large leIer effect. These resources involve personnel and equipment, in particular: equipped clean room and microfabrication station, polymer synthesis and characterisation laboratory, 3 video-microscopes with single-molecule sensitivity, several capillary electrophoresis systems with fluorescence and UV detection, several microfluidic platforms. Because of this large equipment platform, the group does not require extra equipment from EU, for the realization of the project

  • Curie Institute’s Hospital (ICH) is a pioneering treatment centre totally dedicated to cancer treatment, with a specialization in breast cancer and child cancers. It receives per year 75,000 visits, for a total of 30,000 patients (7500 new ones each year). It is at the forefront of clinical research on cancer in France, and comprises a Translational Research Department, providing specific support and reduction of clinical duties, to translational medicine projects involving fundamental researchers and clinicians from the Institute.

  • Cell and Tissues Imaging Facilitiy (CTIF) allows researchers to explore biological samples with up to date optical methods - mainly by fluorescence. Since 2003, the CTIF was recognized as one of 11 national platforms in cellular imaging by the French consortium of RIO, now IBiSA (INSERM-CNRS-INRA-CEA). The digital imaging equipment of the Curie Institute, under the direct responsibilities of the group, includes more than twenty acquisition stations. Among them, eleven correspond to advanced light microscopy systems and seven of those correspond to “homemade” solutions developed by the CTIF team. The group is also responsible of the “image processing and analysis platform”. Although with different competencies, members are experts in dynamic studies using fast four-dimensional video microscopy, image restoration and sophisticated analytical tools. Over the years, the CTIF worked in close partnership with world class industrials in the field of light microscopy (Molecular Devices, Photometrics, Nikon).

Contact persons

To top